Lb Pharmaceuticals Inc.
Clinical trials sponsored by Lb Pharmaceuticals Inc., explained in plain language.
-
New schizophrenia drug enters final safety testing phase
Disease control Not yet recruitingThis study is testing the long-term safety of a medication called LB-102 for adults with stable schizophrenia. It's for people who aren't satisfied with their current antipsychotic medication due to side effects or effectiveness issues and want to switch treatments. The study wil…
Phase: PHASE3 • Sponsor: LB Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New schizophrenia drug enters final testing phase
Disease control Not yet recruitingThis study is testing whether a new medication called LB-102 can help control symptoms during acute schizophrenia episodes. Researchers will compare two different doses of LB-102 against a placebo in 456 adults currently experiencing symptom worsening. The main goal is to see if …
Phase: PHASE3 • Sponsor: LB Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC